High Peripheral Blood Eosinophil (EOS) Levels Are Associated With Low FEV1 Reversibility (REV) In Patients With Severe Eosinophilic Asthma

被引：0
|
作者：
Virchow, J. Christian [1 ]
Hickey, Lisa [2 ]
Garin, Margaret [2 ]
机构：
[1] Univ Rostock, Rostock, Germany
[2] Teva Branded Pharmaceut Prod R&D Inc, Malvern, PA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
14
引用
收藏
页码：AB6 / AB6
页数：1
相关论文
共 50 条
  • [1] In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility
    Virchow, J. Christian
    Hickey, Lisa
    Du, Evelyn
    Garin, Margaret
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [2] In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility
    J. Christian Virchow
    Lisa Hickey
    Evelyn Du
    Margaret Garin
    Allergy, Asthma & Clinical Immunology, 16
  • [3] EOSINOPHILIC AIRWAY INFLAMMATION IS ASSOCIATED WITH FEV1 DECLINE IN SEVERE ASTHMA
    Agbetile, J.
    Desai, D.
    Hargadon, B.
    Bradding, P.
    Wardlaw, A. J.
    Pavord, I. D.
    Green, R. H.
    Brightling, C. E.
    Siddiqui, S.
    THORAX, 2010, 65 : A61 - A61
  • [4] Blood Eosinophil Counts in Patients with Marked FEV1 Reversibility and Fixed Airflow Obstruction
    Riley, S.
    Al-Lehebi, R.
    Gurupatham, S.
    Grbac, E.
    Stanbrook, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
    Sahasrabudhe, Tushar
    Joshi, Madhur
    Oswal, Vikas
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [6] Influence of baseline FEV1 on improvement in severe eosinophilic asthma with mepolizumab
    Barcala, F. Gonzalez
    Blanco-Aparicio, M.
    Gomez-Bastero, A.
    Soto-Campos, G.
    Conejero, D. Banas
    Sanchez-Herrero, M. G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] Responder Analysis For Fev1 Improvement With Dupilumab In Patients With Persistent Asthma And Elevated Eosinophil Levels
    Castro, M.
    Teper, A.
    Wang, L.
    Pirozzi, G.
    Radin, A.
    Graham, N.
    Weinstein, S.
    Wenzel, S. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Exacerbation Reduction In Patients Based Upon Baseline Eosinophil Counts and FEV1 Reversibility
    Yancey, Steven
    Corren, Jonathan
    Price, Robert
    Castro, Mario
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB26 - AB26
  • [9] Change in post-bronchodilator FEV1 for patients with severe asthma with eosinophilic features following benralizumab therapy
    Mathur, S. K.
    Modena, B. D.
    Coumou, H.
    Kamboj, A. P.
    Barker, P.
    Kreindler, J.
    Zangrilli, J. G.
    ALLERGY, 2019, 74 : 28 - 28
  • [10] Increase in blood eosinophil count over time and sputum IL8 are associated with FEV1 decline in asthma
    Graff, S.
    Moermans, C.
    Gerday, S.
    Henket, M.
    Paulus, V
    Guissard, F.
    Louis, R.
    Schleich, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345